Literature DB >> 8454290

Cystic fibrosis in Spain: high frequency of mutation G542X in the Mediterranean coastal area.

T Casals1, V Nunes, A Palacio, J Giménez, A Gaona, N Ibáñez, N Morral, X Estivill.   

Abstract

We have determined the frequency of deletion delta F508 and mutation G542X, a nonsense mutation in exon 11 of the cystic fibrosis (CF) gene, in a sample of 400 Spanish CF families. Mutation G542X represents 8% of the total number of CF mutations in Spain, making it the second most common mutation after the delta F508 deletion, which accounts for 48% of CF chromosomes. G542X has a higher frequency in the Mediterranean coastal area (14%) and in the Canary Islands (25%). About 70% of G542X chromosomes are from Andalucia, Múrcia, Valencia, Catalunya and the Canary Islands. The delta F508 deletion has its highest frequency in the Basque Country (83%). Mutation G542X is associated with the same rare haplotype that is found in association with the delta F508 mutation. The haplotype homogeneity found for G542X, even when intragenic microsatellites (IVS8CA, IVS17BTA and IVS17BCA) are considered, allows us to postulate that this mutation arose from a single mutational event. The geographic distribution of mutations delta F508 and G542X suggests that delta F508 was present in the Iberian Peninsula before the Indo-European invasions, and that G542X was introduced into Spain, via the Mediterranean Sea, probably by the Phoenicians, between 2500 and 3000 years ago.

Entities:  

Mesh:

Year:  1993        PMID: 8454290     DOI: 10.1007/bf00230225

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

1.  Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations.

Authors:  P Gasparini; A Bonizzato; M Dognini; P F Pignatti
Journal:  Mol Cell Probes       Date:  1992-02       Impact factor: 2.365

2.  Prenatal diagnosis of cystic fibrosis by multiplex PCR of mutation and microsatellite alleles.

Authors:  X Estivill; N Morral; T Casals; V Nunes
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

3.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

4.  A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; D Markiewicz; F Rininsland; J Rommens; L C Tsui
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

5.  A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew.

Authors:  H Cuppens; P Marynen; C De Boeck; F De Baets; E Eggermont; H Van den Berghe; J J Cassiman
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

6.  Modification of enzymatically amplified DNA for the detection of point mutations.

Authors:  A Haliassos; J C Chomel; L Tesson; M Baudis; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossingover.

Authors:  N Morral; V Nunes; T Casals; X Estivill
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

9.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

10.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

View more
  12 in total

1.  Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes.

Authors:  M Chillón; T Casals; J Giménez; M D Ramos; A Palacio; N Morral; X Estivill; V Nunes
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

2.  Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation.

Authors:  E Kanavakis; M Tzetis; T Antoniadi; J Traeger-Synodinos; S Doudounakis; G Adam; N Matsaniotis; C Kattamis
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

3.  Estimating the age of alleles by use of intraallelic variability.

Authors:  M Slatkin; B Rannala
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure.

Authors:  G Castaldo; E Rippa; G Sebastio; V Raia; P Ercolini; G de Ritis; D Salvatore; F Salvatore
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

5.  Molecular basis of cystic fibrosis disease: an Indian perspective.

Authors:  R Prasad; H Sharma; G Kaur
Journal:  Indian J Clin Biochem       Date:  2010-11-19

6.  Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis.

Authors:  Rosana Hernando; María Estrella Drobnic; María Jesús Cruz; Adelaida Ferrer; Pilar Suñé; J Bruno Montoro; Ramon Orriols
Journal:  Int J Clin Pharm       Date:  2012-06-09

7.  Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis.

Authors:  E Caballero; M E Drobnic; M T Pérez; J M Manresa; A Ferrer; R Orriols
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

8.  Cystic fibrosis in a low-incidence population: two major mutations in Finland.

Authors:  J Kere; X Estivill; M Chillón; N Morral; V Nunes; R Norio; E Savilahti; A de la Chapelle
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

9.  Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected.

Authors:  T Casals; L Bassas; J Ruiz-Romero; M Chillón; J Giménez; M D Ramos; G Tapia; H Narváez; V Nunes; X Estivill
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

10.  Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele.

Authors:  Angela Polizzi; Riccardina Tesse; Teresa Santostasi; Anna Diana; Antonio Manca; Vito Paolo Logrillo; Maria Domenica Cazzato; Maria Giuseppa Pantaleo; Lucio Armenio
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.